Armando Martins - Profarma Distribuidora Director
| PFRM3 Stock | BRL 5.35 0.03 0.56% |
Director
Mr. Armando Sereno Diogenes Martins has served as a Member of the Board of Directors of Profarma Distribuidora de Produtos Farmaceuticos SA since April 3, 2008. From 1989 to 1991, he was Financial Consultant at Accenture in the financial institutions sector. He was also Business Development Officer for Grupo Arbi. From 1994 to 1998, he was Senior Officer of Banco de Investimentos Garantia. He was Officer at Credit Suisse First Boston CSFB in Brazil for five years. He founded Singular Assessoria Financeira Ltda in 2003. He gained a degree from New York University and a Bachelor in Telecommunications Engineering from Instituto Militar de Engenharia . since 2008.
| Age | 42 |
| Tenure | 16 years |
| Phone | 55 21 4009 0200 |
| Web | https://www.profarma.com.br |
Profarma Distribuidora Management Efficiency
The company has return on total asset (ROA) of 0.0368 % which means that it generated a profit of $0.0368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0645 %, meaning that it generated $0.0645 on every $100 dollars invested by stockholders. Profarma Distribuidora's management efficiency ratios could be used to measure how well Profarma Distribuidora manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Marcelo Galvao | Odontoprev SA | N/A | |
| Eduardo Toledo | Odontoprev SA | 54 | |
| Carlos Rogoginsky | Odontoprev SA | N/A | |
| Fernando Mitri | Positivo Tecnologia SA | 66 | |
| Gabriel Esteves | Mills Estruturas e | N/A | |
| Luiz Belluzzo | JHSF Participaes SA | 69 | |
| Thiago Oliveira | JHSF Participaes SA | 52 | |
| Alvaro Amaral | Positivo Tecnologia SA | 62 | |
| Roberto Pedote | Mills Estruturas e | N/A | |
| Samuel Santos | Odontoprev SA | 73 | |
| Claudio Bonomi | JHSF Participaes SA | N/A | |
| Romeo Busarello | Tecnisa SA | N/A | |
| Victor Foroni | JHSF Participaes SA | N/A | |
| Diego Bush | Mills Estruturas e | N/A | |
| Aymar Almeida | Mills Estruturas e | N/A | |
| Daniel Brugioni | Mills Estruturas e | N/A | |
| Gerald Reiss | Odontoprev SA | 73 | |
| Ruben Formighieri | Positivo Tecnologia SA | 56 | |
| Murilo Passos | Odontoprev SA | 72 | |
| Jorge Camargo | Mills Estruturas e | N/A | |
| Fabio Bruggioni | Mills Estruturas e | N/A | |
Management Performance
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 |
Profarma Distribuidora Leadership Team
Elected by the shareholders, the Profarma Distribuidora's board of directors comprises two types of representatives: Profarma Distribuidora inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Profarma. The board's role is to monitor Profarma Distribuidora's management team and ensure that shareholders' interests are well served. Profarma Distribuidora's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Profarma Distribuidora's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sammy Birmarcker, CEO, Member of the Executive Board, Chairman of the Board | ||
| Armando Martins, Director | ||
| Fernando Perrone, Independent Director | ||
| Adriano Prado, Member Officers | ||
| Maximiliano Fischer, CFO, Director of Investor Relations, Member of the Executive Board | ||
| Dan Ioschpe, Independent Director | ||
| Manoel Birmarcker, Vice Chairman of the Board |
Profarma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Profarma Distribuidora a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 122.61 M | |||
| Shares Owned By Insiders | 66.17 % | |||
| Shares Owned By Institutions | 26.52 % | |||
| Price To Earning | (6.45) X | |||
| Price To Book | 0.35 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Profarma Distribuidora using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profarma Distribuidora de. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Profarma Stock analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |